141 related articles for article (PubMed ID: 21969987)
1. Survival models in health economic evaluations: balancing fit and parsimony to improve prediction.
Jackson CH; Sharples LD; Thompson SG
Int J Biostat; 2010; 6(1):Article 34. PubMed ID: 21969987
[TBL] [Abstract][Full Text] [Related]
2. Bayesian Solutions for Handling Uncertainty in Survival Extrapolation.
Negrín MA; Nam J; Briggs AH
Med Decis Making; 2017 May; 37(4):367-376. PubMed ID: 27281336
[TBL] [Abstract][Full Text] [Related]
3. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Cooper NJ; Sutton AJ; Abrams KR
Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
[TBL] [Abstract][Full Text] [Related]
4. How Uncertain is the Survival Extrapolation? A Study of the Impact of Different Parametric Survival Models on Extrapolated Uncertainty About Hazard Functions, Lifetime Mean Survival and Cost Effectiveness.
Kearns B; Stevens J; Ren S; Brennan A
Pharmacoeconomics; 2020 Feb; 38(2):193-204. PubMed ID: 31761997
[TBL] [Abstract][Full Text] [Related]
5. How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017.
Gallacher D; Auguste P; Connock M
Int J Technol Assess Health Care; 2019 Jan; 35(2):160-167. PubMed ID: 31017564
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
7. Comparing Bayesian spatial models: Goodness-of-smoothing criteria for assessing under- and over-smoothing.
Duncan EW; Mengersen KL
PLoS One; 2020; 15(5):e0233019. PubMed ID: 32433653
[TBL] [Abstract][Full Text] [Related]
8. A flexible parametric approach to examining spatial variation in relative survival.
Cramb SM; Mengersen KL; Lambert PC; Ryan LM; Baade PD
Stat Med; 2016 Dec; 35(29):5448-5463. PubMed ID: 27503837
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian nonparametric approach to marginal structural models for point treatments and a continuous or survival outcome.
Roy J; Lum KJ; Daniels MJ
Biostatistics; 2017 Jan; 18(1):32-47. PubMed ID: 27345532
[TBL] [Abstract][Full Text] [Related]
10. Semiparametric Bayesian survival analysis using models with log-linear median.
Lin J; Sinha D; Lipsitz S; Polpo A
Biometrics; 2012 Dec; 68(4):1136-45. PubMed ID: 23013249
[TBL] [Abstract][Full Text] [Related]
11. A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis.
Levy JF; Rosenberg MA
Med Decis Making; 2019 Jul; 39(5):593-604. PubMed ID: 31409187
[No Abstract] [Full Text] [Related]
12. Spatial smoothing in Bayesian models: a comparison of weights matrix specifications and their impact on inference.
Duncan EW; White NM; Mengersen K
Int J Health Geogr; 2017 Dec; 16(1):47. PubMed ID: 29246157
[TBL] [Abstract][Full Text] [Related]
13. Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study.
Gallacher D; Kimani P; Stallard N
Med Decis Making; 2021 Jan; 41(1):37-50. PubMed ID: 33283635
[TBL] [Abstract][Full Text] [Related]
14. Direct Incorporation of Expert Opinion into Parametric Survival Models to Inform Survival Extrapolation.
Cooney P; White A
Med Decis Making; 2023 Apr; 43(3):325-336. PubMed ID: 36647200
[TBL] [Abstract][Full Text] [Related]
15. Extrapolation of Survival Curves from Cancer Trials Using External Information.
Guyot P; Ades AE; Beasley M; Lueza B; Pignon JP; Welton NJ
Med Decis Making; 2017 May; 37(4):353-366. PubMed ID: 27681990
[TBL] [Abstract][Full Text] [Related]
16. A dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease.
Haeussler K; den Hout AV; Baio G
BMC Med Res Methodol; 2018 Aug; 18(1):82. PubMed ID: 30068316
[TBL] [Abstract][Full Text] [Related]
17. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
Adrion C; Mansmann U
BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
Acevedo JR; Fero KE; Wilson B; Sacco AG; Mell LK; Coffey CS; Murphy JD
J Clin Oncol; 2016 Nov; 34(32):3886-3891. PubMed ID: 27551113
[TBL] [Abstract][Full Text] [Related]
19. Bayesian regularization for flexible baseline hazard functions in Cox survival models.
Lázaro E; Armero C; Alvares D
Biom J; 2021 Jan; 63(1):7-26. PubMed ID: 32885493
[TBL] [Abstract][Full Text] [Related]
20. Bayesian semiparametric models for survival data with a cure fraction.
Ibrahim JG; Chen MH; Sinha D
Biometrics; 2001 Jun; 57(2):383-8. PubMed ID: 11414560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
